Colgate Palmolive (CL) Change in Accured Expenses (2009 - 2025)

Colgate Palmolive's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at $278.0 million for Q3 2025.

• On a quarterly basis, Change in Accured Expenses rose 109.02% year-over-year to $278.0 million in Q3 2025; TTM through Sep 2025 was $219.0 million, a 53.21% decrease from a year earlier, with the FY2024 full-year figure at $516.0 million, up 66.99% from the prior year.
• Change in Accured Expenses climbed to $278.0 million in Q3 2025 per CL's latest filing, from -$191.0 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $278.0 million in Q3 2025 and bottomed at -$191.0 million in Q2 2025.
• The 5-year median for Change in Accured Expenses is $15.0 million (2023), against an average of $39.7 million.
• Across the five-year window, Change in Accured Expenses jumped 786.67% in 2024 and tumbled 812.5% in 2025, its largest moves.
• Year by year, Change in Accured Expenses stood at $121.0 million in 2021, then tumbled by 202.48% to -$124.0 million in 2022, then surged by 213.71% to $141.0 million in 2023, then surged by 34.04% to $189.0 million in 2024, then soared by 47.09% to $278.0 million in 2025.
• Per Business Quant, the three latest CL Change in Accured Expenses figures stand at $278.0 million (Q3 2025), -$191.0 million (Q2 2025), and -$57.0 million (Q1 2025).